Innoviva, Inc.
INVA
$21.46
$0.020.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 128.72M | 116.98M | 107.37M | 88.62M | 71.19M |
| Total Other Revenue | 241.13M | 241.73M | 245.38M | 241.88M | 240.40M |
| Total Revenue | 369.84M | 358.71M | 352.75M | 330.50M | 311.59M |
| Cost of Revenue | 52.94M | 47.96M | 67.13M | 67.36M | 80.30M |
| Gross Profit | 316.90M | 310.76M | 285.61M | 263.13M | 231.29M |
| SG&A Expenses | 112.78M | 115.69M | 110.68M | 113.10M | 108.90M |
| Depreciation & Amortization | 25.94M | 25.90M | 25.90M | 25.90M | 24.42M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 185.39M | 183.28M | 176.66M | 179.71M | 186.97M |
| Operating Income | 184.45M | 175.43M | 176.08M | 150.79M | 124.62M |
| Income Before Tax | -46.33M | 37.39M | 73.90M | 153.00M | 198.08M |
| Income Tax Expenses | 13.40M | 14.00M | 9.30M | 7.57M | 16.69M |
| Earnings from Continuing Operations | -59.72 | 23.39 | 64.59 | 145.42 | 181.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.72M | 23.39M | 64.59M | 145.42M | 181.39M |
| EBIT | 184.45M | 175.43M | 176.08M | 150.79M | 124.62M |
| EBITDA | 210.50M | 201.46M | 202.11M | 176.82M | 149.17M |
| EPS Basic | -0.95 | 0.37 | 1.01 | 2.25 | 2.83 |
| Normalized Basic EPS | 1.80 | 1.69 | 1.66 | 1.40 | 1.13 |
| EPS Diluted | -1.00 | 0.21 | 0.69 | 1.65 | 2.23 |
| Normalized Diluted EPS | 1.68 | 1.49 | 1.47 | 1.18 | 0.91 |
| Average Basic Shares Outstanding | 250.43M | 250.91M | 251.99M | 254.37M | 257.19M |
| Average Diluted Shares Outstanding | 272.39M | 294.21M | 295.00M | 318.22M | 321.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |